Clinical trial design for primary brain tumors: a problem-based framework for neuro-oncology practice
Diego Gómez-Puerto, Jesús Yaringaño, Antonio Di Muzio, Oriol Mirallas, María Vieito · 2026
Read Clinical trial design for primary brain tumors: a problem-based framework for neuro-oncology practice by Diego Gómez-Puerto, Jesús Yaringaño, Antonio Di Muzio, Oriol Mirallas, María Vieito (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13583912.txt.
Description
Diego Gómez-Puerto and co-authors offer a problem-based frame for designing clinical trials in primary brain tumors. Brain tumor trials often yield answers that cannot be read or cannot be generalized. The causes are known: the drug misses the tumor's biology, too little drug gets in, entry rules are too tight, the subtype is rare, controls shift, or endpoints are murky. The trouble, the authors argue, is not a lack of modern methods. It is picking and mixing them by habit rather than by the chief threat at hand.
Their synthesis draws on methods literature, consensus advice, regulator guidance, and past trials. For each design problem they ask four things: the problem, how it fails, the design response, and what doubt remains. Past trials make the lesson plain: biomarker picks and minority responses have both failed to confirm.
Catalog record
| CREATOR | Diego Gómez-Puerto, Jesús Yaringaño, Antonio Di Muzio, Oriol Mirallas, María Vieito |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |